NO944790L - Anvendelse av 3,5-diamino-6-(2,3-diklorfenyl)-1,2,4-triazinisetionat for behandling og hindring av avhengighet, toleranse og sensitivering av medikamenter - Google Patents

Anvendelse av 3,5-diamino-6-(2,3-diklorfenyl)-1,2,4-triazinisetionat for behandling og hindring av avhengighet, toleranse og sensitivering av medikamenter

Info

Publication number
NO944790L
NO944790L NO944790A NO944790A NO944790L NO 944790 L NO944790 L NO 944790L NO 944790 A NO944790 A NO 944790A NO 944790 A NO944790 A NO 944790A NO 944790 L NO944790 L NO 944790L
Authority
NO
Norway
Prior art keywords
tolerance
dichlorophenyl
diamino
triazine
pct
Prior art date
Application number
NO944790A
Other languages
English (en)
Other versions
NO944790D0 (no
NO306451B1 (no
Inventor
Meire Nakamura-Craig
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO944790L publication Critical patent/NO944790L/no
Publication of NO944790D0 publication Critical patent/NO944790D0/no
Publication of NO306451B1 publication Critical patent/NO306451B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO944790A 1992-06-12 1994-12-09 Anvendelse av 3,5-diamino-6-(2,3-diklorfenyl)-1,2,4-triazinisetionat for behandling og hindring av avhengighet, toleranse og sensitivering av medikamenter, triazinisetionatets blanding med et avhengighetsinduserende middel, et preparat og et pro NO306451B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (no) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use
PCT/GB1993/001243 WO1993025207A1 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs

Publications (3)

Publication Number Publication Date
NO944790L true NO944790L (no) 1994-12-09
NO944790D0 NO944790D0 (no) 1994-12-09
NO306451B1 NO306451B1 (no) 1999-11-08

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944790A NO306451B1 (no) 1992-06-12 1994-12-09 Anvendelse av 3,5-diamino-6-(2,3-diklorfenyl)-1,2,4-triazinisetionat for behandling og hindring av avhengighet, toleranse og sensitivering av medikamenter, triazinisetionatets blanding med et avhengighetsinduserende middel, et preparat og et pro

Country Status (23)

Country Link
US (1) US5801171A (no)
EP (1) EP0644763B1 (no)
JP (1) JP3439211B2 (no)
KR (1) KR100268823B1 (no)
AT (1) ATE147980T1 (no)
AU (1) AU688729B2 (no)
CA (1) CA2137782A1 (no)
CZ (1) CZ284061B6 (no)
DE (1) DE69307705T2 (no)
DK (1) DK0644763T3 (no)
ES (1) ES2097516T3 (no)
GB (1) GB2282326A (no)
GR (1) GR3022671T3 (no)
HR (1) HRP930964B1 (no)
IL (1) IL105986A (no)
MY (1) MY109330A (no)
NO (1) NO306451B1 (no)
NZ (1) NZ253260A (no)
SI (1) SI9300318A (no)
SK (1) SK279730B6 (no)
TW (1) TW284689B (no)
WO (1) WO1993025207A1 (no)
YU (1) YU48573B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530999B2 (en) * 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
CA2137782A1 (en) 1993-12-23
MY109330A (en) 1997-01-31
KR100268823B1 (ko) 2000-12-01
IL105986A (en) 1998-12-06
HRP930964A2 (en) 1996-02-29
YU41093A (sh) 1996-10-09
ES2097516T3 (es) 1997-04-01
JP3439211B2 (ja) 2003-08-25
SK279730B6 (sk) 1999-02-11
EP0644763A1 (en) 1995-03-29
TW284689B (no) 1996-09-01
SI9300318A (en) 1994-03-31
GR3022671T3 (en) 1997-05-31
CZ284061B6 (cs) 1998-08-12
NZ253260A (en) 1997-05-26
SK153494A3 (en) 1996-01-10
GB2282326A (en) 1995-04-05
DE69307705T2 (de) 1997-05-22
DK0644763T3 (da) 1997-07-28
ATE147980T1 (de) 1997-02-15
EP0644763B1 (en) 1997-01-22
AU4345293A (en) 1994-01-04
KR950701814A (ko) 1995-05-17
AU688729B2 (en) 1998-03-19
YU48573B (sh) 1998-12-23
JPH07507790A (ja) 1995-08-31
DE69307705D1 (de) 1997-03-06
GB9423697D0 (en) 1995-01-11
CZ312894A3 (en) 1995-07-12
NO944790D0 (no) 1994-12-09
WO1993025207A1 (en) 1993-12-23
HRP930964B1 (en) 2000-06-30
IL105986A0 (en) 1993-10-20
US5801171A (en) 1998-09-01
NO306451B1 (no) 1999-11-08

Similar Documents

Publication Publication Date Title
GR3029568T3 (en) Pyrazoles and pyrazolopyrimidines having crf antagonist activity.
CZ176595A3 (en) The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes
GB9317636D0 (en) Use of dexmedetomidine
BR9306361A (pt) Agentes para o tratamento de desordens resultantes do abuso de substâncias
NO944790L (no) Anvendelse av 3,5-diamino-6-(2,3-diklorfenyl)-1,2,4-triazinisetionat for behandling og hindring av avhengighet, toleranse og sensitivering av medikamenter
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
MX9300927A (es) Compuestos terapeuticos de triazina y su empleo.
NO981222D0 (no) Ny kombinasjon av en <beta>-reseptorblokker og et opioid
RU94046273A (ru) Применение изэтионата 3,5-диамино-6-(2,3-дихлорфенил)-1,2,4-триазина для лечения и предупреждения зависимости, толерантности и сенсибилизации к лекарственным средствам, средство, содержащее 3,5-диамино-6-(2,3-дихлорфенил)-1,2,4-триазин, способ предупреждения и лечения зависимости, композиции и продукт, содержащие 3,5-диамино-6-(2,3-дихлорфенил-1,2,4-триазин)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001